SAT0256 EFFICACY AND SAFETY OF ANTIFIBROTIC THERAPY IN DIFFUSE INTERSTITIAL PULMONARY DISEASE ASSOCIATED WITH SYSTEMIC AUTOIMMUNE DISEASES | Publicación